NZX Retirement Village Stocks: Ryman vs Summerset vs Oceania in 2026

One Tailwind, Three Very Different Stories

New Zealand's population is ageing, and the number of people over 75 is set to climb for decades. That is about as reliable a long-term demand story as the NZX offers, and it is why retirement village operators attract investors looking past the noise of any single year. But betting on the theme is not the same as betting on any one stock. The three listed operators, Ryman Healthcare, Summerset Group and Oceania Healthcare, share a tailwind and almost nothing else in 2026.

Before comparing them, it helps to understand how they actually make money, because it is unusual.

How Retirement Villages Make Money

Operators build villages and sell residents an "occupation right agreement" rather than the freehold. When a resident leaves, the operator keeps a slice of the original price, the deferred management fee, typically 20% to 30%, and then resells the unit, often at a higher price. So the model has three engines: development margins on new units, that deferred management fee, and the uplift when units are resold in a rising market.

That last engine is the catch. When house prices fall or stall, resale gains shrink and units sell more slowly, which ties up cash. This is why these are not defensive stocks despite the defensive-sounding demographics. They are, in large part, geared plays on the New Zealand housing market. As our methodology stresses, understanding how a company actually earns its money matters more than any single ratio.

Summerset: The Steady Performer

Summerset Group has been the standout. It trades around $10.71, remains solidly profitable, and continues to pay a dividend, with FY2025 revenue up about 14% to roughly $362 million and net income near $260 million. Summerset has kept building at pace and managing its balance sheet conservatively enough to keep rewarding shareholders while its larger rival retrenched. It is the closest thing the sector has to a market darling, which is also why it rarely looks cheap.

Ryman: The Fallen Giant Rebuilding

Ryman Healthcare is the cautionary tale. It is still the biggest operator by revenue, at about $856 million in FY2026, up 13%, yet the share price sits near $2.48, a long way below its former highs. The reason is a painful balance-sheet reset. After heavy debt and a tough Australasian property market, Ryman raised large amounts of new equity and suspended its dividend towards the end of FY2023. Management does not expect dividends to return until FY2028.

The FY2026 numbers show a company still in the workshop: a net loss of about $171 million, though that loss narrowed by roughly 61% year on year, a sign the repair is progressing. For investors, Ryman is a turnaround bet. The upside is a large, established operator trading at a depressed valuation; the risk is that the recovery takes longer than hoped and there is no dividend to pay you while you wait.

Oceania: The Small-Cap Play

Oceania Healthcare is the minnow of the trio, trading around $0.81. It combines retirement villages with a larger aged-care (hospital and rest-home) business than its rivals, which changes the economics: care is lower margin and more labour-intensive, but less exposed to property resale cycles. Oceania is the higher-risk, lower-priced option, more sensitive to care-sector funding and staffing pressures than to house prices alone.

What to Watch Across All Three

• •The housing market: resale gains and development margins all lean on property prices. A recovery helps everyone; a fresh downturn hurts.
• •Interest rates: these are capital-intensive, often geared businesses. Falling rates ease funding costs and support property values.
• •Development pace: build too fast into a soft market and cash gets trapped in unsold stock; build too slowly and you forfeit the demographic tailwind.
• •Care funding: government subsidies and staffing costs matter most for Oceania, but affect all operators with care beds.

Which One for Which Investor

If you want proven profitability and income today, Summerset is the quality choice, provided you accept a premium price. If you are comfortable with a multi-year turnaround and no dividend until FY2028, Ryman offers the most recovery upside from a beaten-down base. And if you want a small-cap with a heavier care-sector tilt, Oceania is the contrarian pick. Investors drawn to the property angle might also compare these operators with pure developers such as Winton Land, which shares the housing-market exposure without the care obligations.

The Bottom Line

The demographic bull case for New Zealand retirement villages is genuine and durable. But the three listed operators express it in completely different ways: Summerset as a profitable compounder, Ryman as a balance-sheet turnaround, and Oceania as a small-cap care-and-villages hybrid. The shared bear case is that all three ultimately ride the housing cycle, so a weak property market can overwhelm the demographic story for years at a time. Pick the risk profile that matches your patience.

For how we weigh turnaround risk and cyclical earnings, see our methodology.

*Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice. Stock data may not be real-time. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.*